Synthetic biology between challenges and risks: suggestions for a model of governance and a regulatory framework, based on fundamental rights

• Autores: Ilaria Anna Colussi
• Localización: Revista de derecho y genoma humano: genética, biotecnología y medicina avanzada, ISSN 1134-7198, Nº 38, 2013, págs. 185-214
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • This paper deals with the emerging synthetic biology, its challenges and risks, and tries to design a model for the governance and regulation of the field. The model is called of “prudent vigilance” (inspired by the report about synthetic biology, drafted by the U.S. Presidential Commission on Bioethics, 2010), and it entails (a) an ongoing and periodically revised process of assessment and management of all the risks and concerns, and (b) the adoption of policies - taken through “hard law” and “soft law” sources - that are based on the principle of proportionality (among benefits and risks), on a reasonable balancing between different interests and rights at stake, and are oriented by a constitutional frame, which is represented by the protection of fundamental human rights emerging in the field of synthetic biology (right to life, right to health, dignity, freedom of scientific research, right to environment). After the theoretical explanation of the model, its operability is “checked”, by considering its application with reference to only one specific risk brought up by synthetic biology – biosecurity risk, i.e. the risk of bioterrorism